Wegovys injection delivered roughly 15% average weight loss, and the pills OASIS 4 results show approximately 1416.6% depending on adherence clinically comparable outcomes
Clinical trials have shown significant weight loss compared to not using the drug
Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. Where some medtech leaders might see GLP-1 drugs as a big threat to their territory, Farrell sees it as an opportunity to funnel more people toward CPAP treatment by boosting awareness of chronic diseases like sleep apnea, and driving more people who suffer from these diseases into treatment pathways they may not have been previously open to or aware of, such as CPAP machines
Inzucchi SE, Tan X, Liang Y, Yedigarova L, Xie L, de Havenon A
Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX
Conclusions In this study, a novel GST of the Mu-class was successfully isolated from H
-1775582746855.png&w=3840&q=75)
